|
"chou s j"的相關文件
顯示項目 31-40 / 46 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T06:57:57Z |
LZF1, a HY5-regulated transcriptional factor, functions in Arabidopsis de-etiolation.
|
Li, Yi-Hang; Chen, Li-Teh; Chen, Wan-Chieh; Hsieh, Wen-Ping; Shin, Jieun; Jane, Wann-Neng; Chou, Shu-Jen; Choi, Giltsu; Hu, Jer-Ming; Somerville, Shauna; Wu, Shu-Hsing; Chang, C.-S.; Li, Y.-H.; Chen, L.-T.; Chen, W.-C.; Hsieh, W.-P.; Shin, J.; Jane, W.-N.; Chou, S.-J.; Choi, G.; Hu, J.-M.; Somerville, S.; Wu, S.-H.; Chang, Chiung-swey Joanne; JER-MING HUet al. |
| 臺大學術典藏 |
2018-09-10T06:31:03Z |
A statistical approach to the timing-yield optimization of pipeline circuits
|
Hsu, C.-H.; Chou, S.-J.; Jiang, J.-H.R.; Chang, Y.-W.; YAO-WEN CHANG |
| 臺大學術典藏 |
2018-09-10T06:31:00Z |
Novel wire density driven full-chip routing for CMP variation control
|
Chen, H.-Y.; Chou, S.-J.; Wang, S.-L.; Chang, Y.-W.; YAO-WEN CHANG |
| 臺大學術典藏 |
2018-09-10T05:58:34Z |
Current path analysis for electrostatic discharge protection
|
Liu, H.-Y.; Lin, C.-W.; Chou, S.-J.; Tu, W.-T.; Liu, C.-H.; Chang, Y.-W.; Kuo, S.-Y.; YAO-WEN CHANG |
| 臺大學術典藏 |
2018-09-10T04:37:34Z |
Secular trend and geographical variation in hepatitis A infection and hepatitis C carrier rate among adolescents in Taiwan: An island-wide survey
|
YAWEN CHENG; Wang, L.-Y.;Cheng, Y.-W.;Chou, S.-J.;Hsieh, L.-L.;Chen, C.-J. |
| 臺大學術典藏 |
2016 |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
HWEI-FANG TIEN; Cheng C.-L.; Chou S.-J.; Tsay W.; Huang S.-Y.; Lin H.-H.; Lin C.-W.; Li C.-C.; Yao M.; Tang J.-L.; Hou H.-A. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
HWEI-FANG TIEN; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Lu H.-Y.; Chen Y.-C.; Wu S.-J.; Tang J.-L.; Lin H.-H.; Yao M.; Huang S.-Y.; Lin C.-W. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
MING YAO; Lin C.-W.; Lin H.-H.; Huang S.-Y.; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Chen Y.-C.; Lu H.-Y.; Wu S.-J.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
SHANG-YI HUANG; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Yao M.; Lin H.-H.; Lin C.-W.; Huang S.-Y.; Tien H.-F.; Tang J.-L.; SHANG-JU WU; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J. |
顯示項目 31-40 / 46 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
